Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies

Abstract Background ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. Methods 416 ICD patients wi...

Full description

Bibliographic Details
Main Authors: Javier Jiménez-Candil, Olga Duran, Armando Oterino, Jendri Pérez, Juan Carlos Castro, Jesús Hernández, José Moríñigo, Manuel Sánchez García, Pedro L. Sánchez
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-021-02087-2
id doaj-93c04e53841242bc9c3c9d46ed8b71b8
record_format Article
spelling doaj-93c04e53841242bc9c3c9d46ed8b71b82021-06-06T11:27:50ZengBMCBMC Cardiovascular Disorders1471-22612021-05-012111910.1186/s12872-021-02087-2Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapiesJavier Jiménez-Candil0Olga Duran1Armando Oterino2Jendri Pérez3Juan Carlos Castro4Jesús Hernández5José Moríñigo6Manuel Sánchez García7Pedro L. Sánchez8Arrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaArrhythmias Unit, Cardiology Department, IBSAL-University Hospital, CIVER-CV, Universidad de SalamancaAbstract Background ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. Methods 416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months. Results We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001. Conclusions Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies.https://doi.org/10.1186/s12872-021-02087-2Implantable cardioverter-defibrillatorVentricular tachycardiaAppropriate therapy
collection DOAJ
language English
format Article
sources DOAJ
author Javier Jiménez-Candil
Olga Duran
Armando Oterino
Jendri Pérez
Juan Carlos Castro
Jesús Hernández
José Moríñigo
Manuel Sánchez García
Pedro L. Sánchez
spellingShingle Javier Jiménez-Candil
Olga Duran
Armando Oterino
Jendri Pérez
Juan Carlos Castro
Jesús Hernández
José Moríñigo
Manuel Sánchez García
Pedro L. Sánchez
Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
BMC Cardiovascular Disorders
Implantable cardioverter-defibrillator
Ventricular tachycardia
Appropriate therapy
author_facet Javier Jiménez-Candil
Olga Duran
Armando Oterino
Jendri Pérez
Juan Carlos Castro
Jesús Hernández
José Moríñigo
Manuel Sánchez García
Pedro L. Sánchez
author_sort Javier Jiménez-Candil
title Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_short Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_full Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_fullStr Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_full_unstemmed Cycle length of nonsustanied ventricular tachycardias among ICD patients: implications on subsequent appropriate therapies
title_sort cycle length of nonsustanied ventricular tachycardias among icd patients: implications on subsequent appropriate therapies
publisher BMC
series BMC Cardiovascular Disorders
issn 1471-2261
publishDate 2021-05-01
description Abstract Background ICD patients with episodes of nonsustained ventricular tachycardias (NSVT) are at risk of appropriate therapies. However, the relationship between the cycle length (CL) of such NSVTs and the subsequent incidence of appropriate interventions is unknown. Methods 416 ICD patients with LVEF < 45% were studied. ICD programming was standardized. NSVT was defined as any VT of 5 or more beats at ≥ 150 bpm occurred in the first 6 months after implantation that terminated spontaneously and was not preceded by any appropriate therapy. The mean follow-up was 41 ± 27 months. Results We analyzed 2201 NSVTs (mean CL = 323 ms) that occurred in 250 patients; 111 of such episodes were fast (CL ≤ 300 ms). Secondary prevention (HR = 1.7; p < 0.001), number of NSVT episodes (HR = 1.05; 95% CI 1.04–1.07; p < 0.001) and beta-blocker treatment (HR = 0.7; p = 0.04) were independent predictors of appropriate interventions; however, the mean CL of NSVTs was not (p = 0.6). There was a correlation between the mean CL of NSVTs and the CL of the first monomorphic VT: r = 0.88; p < 0.001. This correlation was especially robust in individuals with > 5 NSVTs (r = 0.97; p < 0.001), with an agreement between both values greater than 95%. Patients with any fast NSVT experienced a higher incidence of VF episodes (26%) compared to those without NVSTs (3%) or with only slow NSVTs (7%); p < 0.001. Conclusions Unlike the burden, the CL of NSVTs is not a predictor of subsequent appropriate interventions. However, there is a close relationship between the CL of NSVTs and that of arrhythmias that will later lead to appropriate therapies.
topic Implantable cardioverter-defibrillator
Ventricular tachycardia
Appropriate therapy
url https://doi.org/10.1186/s12872-021-02087-2
work_keys_str_mv AT javierjimenezcandil cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT olgaduran cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT armandooterino cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT jendriperez cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT juancarloscastro cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT jesushernandez cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT josemorinigo cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT manuelsanchezgarcia cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
AT pedrolsanchez cyclelengthofnonsustaniedventriculartachycardiasamongicdpatientsimplicationsonsubsequentappropriatetherapies
_version_ 1721393981044031488